Comprehensive Analysis Identifies <i>THEMIS2</i> as a Potential Prognostic and Immunological Biomarker in Glioblastoma
Glioblastoma (GBM) is a highly aggressive brain tumor characterized by its ability to evade the immune system, hindering the efficacy of current immunotherapies. Recent research has highlighted the important role of immunosuppressive macrophages in the tumor microenvironment (TME) in driving this im...
Saved in:
Main Authors: | Jianan Chen, Qiong Wu, Anders E. Berglund, Robert J. Macaulay, Arnold B. Etame |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/2/66 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploration and Verification of Prognostic Value of Endothelial Cells in Glioblastoma
by: Hengchao MA, et al.
Published: (2025-01-01) -
Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
by: Meifang Li, et al.
Published: (2025-02-01) -
Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppression
by: Shankar Suman, et al.
Published: (2025-01-01) -
Role of Virtual iMRI in Glioblastoma Surgery: Advantages, Limitations, and Correlation with iCT and Brain Shift
by: Erica Grasso, et al.
Published: (2024-12-01) -
Agrobacterium-mediated transformation of <i>Nicotiana glauca</i> and <i>Nicotiana sylvestris</i>
by: G. V. Khafizova, et al.
Published: (2022-11-01)